Skip Nav Destination
Issues
1 July 2019
-
Cover Image
Cover Image
ABOUT THE COVER
Lung cancer and chronic obstructive pulmonary disease (COPD) are mainly caused by smoking. The five-year survival rate for patients with lung cancer has not improved over the last three decades, and COPD is expected to become the third most common cause of death by 2020. A COPD diagnosis increases the risk of lung cancer development up to 4.5 times. Therefore, it is important to understand the common molecular mechanism(s) driving these two devastating diseases in concert and discover dietary components or pharmacologic agents that can prevent or delay the progression of lung cancer and COPD.
A study by Rakic and colleagues (beginning on page 421) demonstrates that ferrets exposed to a carcinogen in combination with cigarette smoke developed COPD accompanied by preneoplastic and neoplastic lesions in the lungs, suggesting ferrets as an excellent model for studying COPD and lung cancer in preclinical settings. The authors further demonstrate that feeding with lycopene, a carotenoid found in tomatoes, inhibited carcinogen- and cigarette smoke exposure–induced COPD and lung carcinogenesis. Lycopene is effective in upregulating critical genes related to the reverse cholesterol transport pathway, resulting in restoration of total cholesterol concentrations in lung and plasma to normal. These results suggest that lycopene may inhibit COPD and lung cancer development by maintaining pulmonary cholesterol homeostasis. The cover depicts a ferret, the model animal used in this study. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Review
Research Articles
Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer
Urszula Dougherty; Reba Mustafi; Haider I. Haider; Abdurahman Khalil; Jeffrey S. Souris; Loren Joseph; John Hart; Vani J. Konda; Wei Zhang; Joel Pekow; Yan Chun Li; Marc Bissonnette
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)
Katherine D. Crew; Garnet L. Anderson; Dawn L. Hershman; Mary Beth Terry; Parisa Tehranifar; Danika L. Lew; Monica Yee; Eric A. Brown; Sebastien S. Kairouz; Nafisa Kuwajerwala; Therese Bevers; John E. Doster; Corrine Zarwan; Laura Kruper; Lori M. Minasian; Leslie Ford; Banu Arun; Marian Neuhouser; Gary E. Goodman; Powel H. Brown
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.